Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Vascular Solutions Inc Raises FY 2012 Revenue Guidance; Raises Low End Of Prior FY 2012 EPS Guidance; Issues Q4 2012 Guidance In Line With Analysts' Estimates


Thursday, 18 Oct 2012 04:05pm EDT 

Vascular Solutions Inc announced that for fiscal 2012, it expects net revenue to between $98.1-$99.1 million, net earnings to between $0.58-$0.59 per fully diluted share. For fourth quarter of 2012, it expects net revenue of between $25.0-$26.0 million and net earnings to be between $0.16-$0.17 per diluted share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $98.9 million and EPS of $0.58 for fiscal 2012; revenue of $25.6 million and EPS of $0.16 for fourth quarter of 2012.